Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Presurgical Letrozole in Early-stage Breast Cancer
NCT02010021Completed
- Sponsor
- Dartmouth Health
- Start
- Jan 2014
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of letrozole in breast cancer, sponsored by Dartmouth Health. Primary endpoint: Change in Insulin Receptor Substrate 1 / Phosphoinositide 3-kinase / Serine-threonine Protein Kinase Pathway Activation at 30 days. Started Jan 2014; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02010021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02010021.